Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yatender Kumar

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Journal of Biomolecular Structure & Dynamics|January 4, 2024
Structural and functional analysis of engineered antibodies for cancer immunotherapy: insights into protein compactness and solvent accessibilitySamvedna Saini, Yatender Kumar
Journal of Alzheimer'S Disease Reports|December 24, 2019
Nature's Derivative(s) as Alternative Anti-Alzheimer's Disease TreatmentsAnuja Sharma, Yatender Kumar
Veterinary Research Communications|April 23, 2026
Deep learning for stenotic nares classification in brachycephalic dogsMuskan Chauhan, Yatender Kumar
Human Vaccines & Immunotherapeutics|July 3, 2020
Bispecific antibodies: a novel approach for targeting prominent biomarkersAkshita Gupta, Yatender Kumar
Journal of Biomolecular Structure & Dynamics|June 19, 2023
Investigating the structural impact of Omicron RBD mutation on antibody escape and receptor managementSamvedna Saini, Savita Pareekh, Yatender Kumar
World Journal of Microbiology & Biotechnology|August 11, 2021
Cytolethal distending toxin: from genotoxin to a potential biomarker and anti-tumor targetSwadha Kailoo, Shreya, Yatender Kumar
Acta Neurologica Belgica|February 29, 2012
Influence of carvedilol on anticonvulsant effect of gabapentinRadha Goel, Amit Goel, Yatender Kumar
The Biochemical Journal|January 21, 2010
Interaction with Sug1 enables Ipaf ubiquitination leading to caspase 8 activation and cell deathYatender Kumar, Vegesna Radha, Ghanshyam Swarup
Indian Journal of Microbiology|July 14, 2025
Targeting Type III Secretion System using <i>Salmonella</i>: A Promising Candidate for Innovative Antibacterial TherapyShreya, Tarun Pant, Swadha Kailoo, et al.
CNS & Neurological Disorders Drug Targets|September 3, 2021
Immunotherapeutics for AD: A Work in ProgressAnuja Sharma, Jaspreet Singh Anand, Yatender Kumar
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Journal of Biomolecular Structure & Dynamics|January 4, 2024
Structural and functional analysis of engineered antibodies for cancer immunotherapy: insights into protein compactness and solvent accessibilitySamvedna Saini, Yatender Kumar
Journal of Alzheimer'S Disease Reports|December 24, 2019
Nature's Derivative(s) as Alternative Anti-Alzheimer's Disease TreatmentsAnuja Sharma, Yatender Kumar
Veterinary Research Communications|April 23, 2026
Deep learning for stenotic nares classification in brachycephalic dogsMuskan Chauhan, Yatender Kumar
Human Vaccines & Immunotherapeutics|July 3, 2020
Bispecific antibodies: a novel approach for targeting prominent biomarkersAkshita Gupta, Yatender Kumar
Journal of Biomolecular Structure & Dynamics|June 19, 2023
Investigating the structural impact of Omicron RBD mutation on antibody escape and receptor managementSamvedna Saini, Savita Pareekh, Yatender Kumar
World Journal of Microbiology & Biotechnology|August 11, 2021
Cytolethal distending toxin: from genotoxin to a potential biomarker and anti-tumor targetSwadha Kailoo, Shreya, Yatender Kumar
Acta Neurologica Belgica|February 29, 2012
Influence of carvedilol on anticonvulsant effect of gabapentinRadha Goel, Amit Goel, Yatender Kumar
The Biochemical Journal|January 21, 2010
Interaction with Sug1 enables Ipaf ubiquitination leading to caspase 8 activation and cell deathYatender Kumar, Vegesna Radha, Ghanshyam Swarup
Indian Journal of Microbiology|July 14, 2025
Targeting Type III Secretion System using <i>Salmonella</i>: A Promising Candidate for Innovative Antibacterial TherapyShreya, Tarun Pant, Swadha Kailoo, et al.
CNS & Neurological Disorders Drug Targets|September 3, 2021
Immunotherapeutics for AD: A Work in ProgressAnuja Sharma, Jaspreet Singh Anand, Yatender Kumar
Pageof 3